10:40Veropharm publishes 1Q 2008 results
We are negative on Veropharm's 1Q 08 results. Although the share of the remunerative prescription medicine segment in the company's total revenue rose to 62%, outrunning expense growth impaired the company's margin indicators. In our opinion, this could have a negative impact on investors' attitude towards the company in the short-term.
10:34Acron to float 10% on LSE
The expected offer price of USD 150 per share for Acron shares may serve as a benchmark for investors in the near future and should lend support to the company's stock valuations, making its shares more liquid in the wake of the placement.
10:16Iskitimcement reports production in 6M 2008
Iskitimcement expanded cement production by 19.6% y-o-y to 897,000 tons in 1H 2008. Our estimates show that the company may produce over 2 million tons of cement in the full year. Although we are upbeat on the news, we do not expect it to have a tangible impact on the company's stock valuations.
10:02Uralchem buys 7.5% in Tolyattiazot for USD 147 mn
Despite the low price at which Uralchem bought a 7.5% share in Tolyattiazot from the Renova group, the emergence of a large publicly-traded chemical holding company among the company's shareholders may spell an end to the ongoing corporate conflict around the company, making it more transparent and helping reveal its fundamental value.
1.169
115.98
